(Q38030840)

27 August 2017

1,5-Anhydroglucitol in diabetes mellitus (English)

1 reference

27 August 2017

Won Jun Kim

1

1 reference

PubMed ID

22847316

27 August 2017

Cheol-Young Park

series ordinal

2

1 reference

27 August 2017

31 July 2012

1 reference

27 August 2017

1 reference

27 August 2017

43

1 reference

27 August 2017

33-40

1 reference

27 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-012-9760-6

27 August 2017

0 references

cites work

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Clinical impact of glycated albumin as another glycemic control marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Evaluation of 1,5-anhydroglucitol, hemoglobin A1c, and glucose levels in youth and young adults with type 1 diabetes and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Habitual intake of dairy products influences serum 1,5-anhydroglucitol levels independently of plasma glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Close relationship between serum concentrations of 1,5-anhydroglucitol and uric acid in non-diabetic male subjects implies common renal transport system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

1,5-Anhydroglucitol levels are low irrespective of plasma glucose levels in patients with chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Lack of correlation between 1,5-anhydroglucitol assay and oral glucose tolerance test in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Na(+) -glucose transporter-2 messenger ribonucleic acid expression in kidney of diabetic rats correlates with glycemic levels: involvement of hepatocyte nuclear factor-1alpha expression and activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Decreased expression of glucose and peptide transporters in rat remnant kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

The application of plasma 1,5-anhydro-D-glucitol for monitoring type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Effects of age and obesity on glycated haemoglobin and 1,5-anhydroglucitol in screening for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Correlation between baseline serum 1,5-anhydroglucitol levels and 2-hour post-challenge glucose levels during oral glucose tolerance tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Is serum anhydroglucitol an alternative to the oral glucose tolerance test for diabetes screening? The Mauritius Noncommunicable Diseases Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Does serum 1,5-anhydroglucitol establish a relationship between improvements in HbA1c and postprandial glucose excursions? Supportive evidence utilizing the differential effects between biphasic insulin aspart 30 and insulin glargine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Serum 1,5-anhydroglucitol levels in patients with fulminant type 1 diabetes are lower than those in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

HNF1alpha controls renal glucose reabsorption in mouse and man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Nontraditional markers of glycemia: associations with microvascular conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Metabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Pro-atherogenic alterations in T-lymphocyte subpopulations related to acute hyperglycaemia in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Serum 1,5-anhydro-D-glucitol levels predict first-ever cardiovascular disease: an 11-year population-based cohort study in Japan, the Suita study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9760-6

Quantification of serum 1,5-anhydroglucitol in uremic and diabetic patients by liquid chromatography/mass spectrometry

21 January 2018

1 reference

12 December 2020

Correlation between 1,5-anhydroglucitol and glycemic excursions in type 2 diabetic patients.

1 reference

12 December 2020

Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus

1 reference

12 December 2020

Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: assay assessment and lower levels in diabetic vs. non-diabetic subjects

1 reference

12 December 2020

Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body

1 reference

12 December 2020

Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus

1 reference

12 December 2020

1,5-anhydroglucitol as a marker for the differential diagnosis of acute and chronic renal failure

1 reference

12 December 2020

Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells

1 reference

12 December 2020

Common reabsorption system of 1,5-anhydro-D-glucitol, fructose, and mannose in rat renal tubule

1 reference

12 December 2020

Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70

1 reference

12 December 2020

1,5-anhydro-D-glucitol: a novel marker of glucose excursions.

1 reference

12 December 2020

Serum concentration and renal handling of 1,5-anhydro-D-glucitol in patients with chronic renal failure

1 reference

12 December 2020

Serum 1,5-anhydroglucitol is low in gastrectomized men

1 reference

12 December 2020

10.1007/S12020-012-9760-6

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

22847316